HCA Healthcare’s (HCA) Outperform Rating Reaffirmed at Royal Bank Of Canada

HCA Healthcare (NYSE:HCA)‘s stock had its “outperform” rating reissued by stock analysts at Royal Bank Of Canada in a research report issued on Tuesday, Benzinga reports. They currently have a $435.00 price target on the stock. Royal Bank Of Canada’s price objective would indicate a potential upside of 7.24% from the stock’s current price.

Other equities research analysts have also issued research reports about the stock. KeyCorp dropped their price objective on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research note on Monday, July 27th. Mizuho lowered their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a report on Tuesday, July 28th. Truist Financial cut their price target on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th. The Goldman Sachs Group dropped their target price on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. Finally, Barclays reduced their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a report on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Stock Performance

Shares of NYSE HCA traded up $0.62 during mid-day trading on Tuesday, hitting $405.62. 283,393 shares of the stock traded hands, compared to its average volume of 1,327,269. The stock has a fifty day moving average price of $403.59 and a 200-day moving average price of $435.91. The company has a market cap of $87.82 billion, a price-to-earnings ratio of 13.56, a PEG ratio of 1.33 and a beta of 1.10. HCA Healthcare has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the firm posted $6.84 earnings per share. As a group, sell-side analysts predict that HCA Healthcare will post 29.42 EPS for the current fiscal year.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently bought and sold shares of HCA. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $26,000. MidFirst Bank bought a new position in HCA Healthcare during the second quarter valued at approximately $28,000. Clearstead Trust LLC purchased a new stake in HCA Healthcare in the second quarter worth approximately $29,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare during the 1st quarter valued at $33,000. Finally, JPL Wealth Management LLC purchased a new position in shares of HCA Healthcare in the 3rd quarter worth $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.